Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
The effectiveness of the Pupil Premium is likely to face further scrutiny following the release of figures by the Department for Education (DfE) which show pupils eligible for free school meals were almost three times as likely to be “persistent absentees” than those who were not eligible (10.6% compared with 3.7% in the Autumn 2011 and Spring 2012 terms).
Children’s charity Barnados has urged schools “to do more to find the root causes for such a stark imbalance between the numbers of poor children missing valuable lesson time and their classmates.”
Studies show a high number of eligible pupils fail to claim free school meals due to the perceived stigma attached, resulting in schools missing out on a significant proportion of potential funds. This raises concerns over the effectiveness of the Pupil Premium in its current form. Arguably the criteria for eligibility should be changed to increase take up and any unclaimed funds should be put towards developing other strategies which can help disadvantaged children.
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Partner and Head of Education
Select which mailings you would like to receive from us.
Sign up